Global Albumin Market Shows Strong Growth Potential Driven by Medical Applications and Biotech Advancements

The global albumin market size was USD 0.88 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period. The global albumin market is experiencing significant growth, fueled by its increasing use in clinical settings, drug formulation, and life-saving treatments for various critical conditions. Key market drivers include the rising demand for non-therapeutic applications, growing preferences for recombinant albumin in therapies, and the increasing prevalence of rare diseases and life-threatening conditions.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2806

Albumin's Role in Clinical Applications and Surgeries

Albumin, a major protein in blood plasma, is widely used in medical treatments, particularly for patients undergoing surgeries, recovering from trauma, burns, or infections, and those suffering from liver diseases. Albumin therapy helps restore lost fluids and blood volume, which is critical in stabilizing patients after such medical events. It is also essential in stabilizing drugs, preventing protein aggregation, oxidation, and surface absorption.

The World Health Organization (WHO) reported approximately 235 million major surgeries globally in 2022, highlighting the critical role albumin plays in surgical care. In the U.S. alone, over 1.8 million new cancer cases were recorded in 2022, many of which required surgical interventions. This increasing number of cancer-related surgeries has led to a rise in demand for albumin, further boosting market growth.

Supporting Rare Disease Treatments and Cellular Therapies

The rise in rare diseases and critical conditions like liver diseases and cardiopulmonary issues has further increased the need for albumin in treatments. Albumin is often administered during cardiopulmonary bypass surgeries and to treat patients suffering from hypoalbuminemia due to severe injuries or pancreatitis. Its widespread clinical use is contributing to steady revenue growth in the global albumin market.

Additionally, albumin's role in facilitating stem cell production, cellular therapies, and regenerative medicine is becoming increasingly important. It is commonly used in cryopreservation to ensure the safe storage and transportation of these delicate biological treatments. The use of Human Serum Albumin (HSA) in maintaining cell integrity during therapy production further strengthens the market's growth trajectory.

Market Constraints and Regulatory Challenges

Despite its promising applications, the global albumin market faces challenges due to stringent regulatory frameworks governing the production and usage of albumin-based products. These regulations are necessary to ensure the safety and efficacy of albumin treatments but can slow down market expansion.

Segment Insights: Leading the Market

Product Segmentation: Human Serum Albumin Takes the Lead

Among product types, the human serum albumin segment accounted for the largest market share in 2022. This dominance is attributed to its wide application in medical research, cell culture, and drug delivery systems. In contrast, recombinant serum albumin is expected to witness the fastest growth during the forecast period, driven by its increasing use in research and development (R&D) activities and therapeutic applications.

Application Segmentation: Therapeutics and Vaccines Drive Growth

The therapeutics segment holds the largest share of the global albumin market due to the rising prevalence of burns, trauma cases, and cardiac disorders. In drug formulation and vaccines, albumin's biochemical properties make it an ideal platform for drug delivery, contributing to fast revenue growth in this segment.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2806

End-Use Segmentation: Hospitals Dominate

Hospitals were the leading end-users of albumin in 2022, driven by its essential role in treating critically ill patients. Albumin is widely used to restore blood volume during surgeries, trauma care, and for patients with hypoalbuminemia due to liver issues or malnutrition. Its use in drug delivery, diagnostics, and therapeutic interventions further strengthens its presence in hospital settings.

Future Outlook: Innovations and Opportunities

The global albumin market is expected to continue growing as new innovations emerge, and the demand for albumin-based therapies increases. Advances in albumin-based treatments, particularly in drug formulation and regenerative medicine, are creating opportunities for the market to expand further. However, overcoming regulatory hurdles will be crucial to unlocking the full potential of this market.

As albumin-based applications broaden in the healthcare and biotechnology sectors, the market is poised for sustained growth in the coming years.

Albumin Top Companies and Competitive Landscape

The global albumin market is fairly fragmented with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective albumin solutions.

Some major players included in the global albumin market report are:

Merck KGaA

CSL Limited

Grifols S.A. (Grifols International, S.A.)

Baxter International Inc.

China Biologic Products Holdings, Inc.

Takeda Pharmaceuticals

Octapharma AG

Novozymes A/S (Albumedix Ltd.)

Thermo Fisher Scientific Inc (Affymetrix, Inc.)

Ventria Bioscience

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/albumin-market

Albumin Latest Industry Updates

In April 2020, Apotex Corp. released its generic version of Abraxane, Paclitaxel protein-bound particles for injection (albumin-bound), which was made available in the US. Adenocarcinoma of the pancreas, non-small cell lung cancer, and metastatic breast cancer are all indicated for treatment with paclitaxel protein-bound particles for injectable suspension.

In May 2020, Bio Products Laboratory (BPL) announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection. The US and are currently in stock. The US Food and Drug Administration has given the drugs ALBUMINEX 5% and ALBUMINEX 25% approval for the treatment of cardiopulmonary bypass, acute nephrosis, acute respiratory distress syndrome (ARDS), ascites, and hypoalbuminemia, including that resulting from burns.

For the purpose of this report, Emergen Research has segmented the global albumin market on the basis of product, application, end-use, and region:

Product Outlook (Revenue, USD Billion; 2019-2032)

Human serum albumin

Bovine serum albumin

Recombinant albumin

Application Outlook (Revenue, USD Billion; 2019-2032)

Therapeutics

Drug formulation & vaccines

Other applications

End-Use Outlook (Revenue, USD Billion; 2019-2032)

Therapeutics

Drug formulation & vaccines

Other applications

Regional Outlook (Revenue, USD Billion; 2019-2032)

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Spain

Benelux

Russia

Rest of Europe

Asia Pacific

China

Japan

South Korea

India

ASEAN Countries

Oceania

Rest of APAC

Latin America

Brazil

Mexico

Rest of LATAM

Middle East & Africa

GCC Countries

Israel

Turkey

South Africa

Rest of MEA

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2806

Look Over transcripts provided by Emergen Research

Albumin Market Size@ https://www.emergenresearch.com/industry-report/albumin-market/market-size

Albumin Market Share@ https://www.emergenresearch.com/industry-report/albumin-market/market-share     

Albumin Market Trends@ https://www.emergenresearch.com/industry-report/albumin-market/market-trends

Albumin Regional Market Demand@ https://www.emergenresearch.com/industry-report/albumin-market/regional-market-demand

Albumin Market Analysis@ https://www.emergenresearch.com/industry-report/albumin-market/market-analysis

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors

This release was published on openPR.